Works about CHRONIC myeloid leukemia
Results: 5000
Toxicity assessment of imatinib mesylate and a related impurity: in vitro and in vivo approaches.
- Published in:
- Toxicology Research, 2025, v. 14, n. 1, p. 1, doi. 10.1093/toxres/tfaf029
- By:
- Publication type:
- Article
Population pharmacokinetic modeling of asciminib in support of exposure-response and ethnic sensitivity analyses in patients with chronic myeloid leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2025, v. 95, n. 1, p. 1, doi. 10.1007/s00280-025-04755-y
- By:
- Publication type:
- Article
Essential Thrombocythemia: A Review.
- Published in:
- JAMA: Journal of the American Medical Association, 2025, v. 333, n. 8, p. 701, doi. 10.1001/jama.2024.25349
- By:
- Publication type:
- Article
Hedgehog and PI3K/Akt/mTOR Signaling Pathways Involvement in Leukemic Malignancies: Crosstalk and Role in Cell Death.
- Published in:
- Cells (2073-4409), 2025, v. 14, n. 4, p. 269, doi. 10.3390/cells14040269
- By:
- Publication type:
- Article
Autophagy and Cancer: Insights into Molecular Mechanisms and Therapeutic Approaches for Chronic Myeloid Leukemia.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 2, p. 215, doi. 10.3390/biom15020215
- By:
- Publication type:
- Article
Eosinophilic Dermatosis of Hematological Malignancy.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Bosutinib-Induced Pleural Effusion—Class Effect and Cross-Intolerance to All Tyrosine Kinase Inhibitors.
- Published in:
- Hematology Reports, 2025, v. 17, n. 1, p. 7, doi. 10.3390/hematolrep17010007
- By:
- Publication type:
- Article
The Resilience of an Urban Rail Transit Network: An Evaluation Approach Based on a Weighted Coupled Map Lattice Model.
- Published in:
- Mathematics (2227-7390), 2025, v. 13, n. 4, p. 608, doi. 10.3390/math13040608
- By:
- Publication type:
- Article
Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 207, doi. 10.1007/s00277-024-06100-4
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of Imatinib: Is There a Rationale for Also Quantifying Its Active Metabolite?
- Published in:
- Chemotherapy (0009-3157), 2025, v. 70, n. 1, p. 26, doi. 10.1159/000541936
- By:
- Publication type:
- Article
Treatment-Emergent Resistance to Asciminib in Chronic Myeloid Leukemia Patients Due to Myristoyl-Binding Pocket-Mutant of BCR::ABL1/A337V Can Be Effectively Overcome with Dasatinib Treatment.
- Published in:
- Current Oncology, 2025, v. 32, n. 2, p. 97, doi. 10.3390/curroncol32020097
- By:
- Publication type:
- Article
Penile juvenile xanthogranuloma and neurofibromatosis type-1: risk association with juvenile myelomonocytic leukaemia?
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Chronic myeloid leukaemia: A guide for practice nurses.
- Published in:
- Practice Nursing, 2017, v. 28, n. 10, p. 419, doi. 10.12968/pnur.2017.28.10.419
- By:
- Publication type:
- Article
Chemotherapy-induced pyoderma gangrenosum.
- Published in:
- World Council of Enterostomal Therapists Journal, 2019, v. 39, n. 1, p. 9, doi. 10.33235/wcet.39.1.9-17
- By:
- Publication type:
- Article
Therapeutic Plateletpheresis in a Case of Symptomatic Thrombocytosis in Chronic Myeloid Leukemia.
- Published in:
- Therapeutic Apheresis & Dialysis, 2004, v. 8, n. 6, p. 497, doi. 10.1111/j.1774-9987.2004.00187.x
- By:
- Publication type:
- Article
Induction of Differentiation in K562 Cell Line by Nicotinic Acid-Related Compounds.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2009, v. 73, n. 1, p. 79, doi. 10.1271/bbb.80483
- By:
- Publication type:
- Article
Correspondence on "Synergy and Antagonism between Allosteric and Active‐Site Inhibitors of Abl Tyrosine Kinase"**.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 46, p. 1, doi. 10.1002/ange.202117276
- By:
- Publication type:
- Article
An Artemisinin‐Derivative–(NHC)Gold(I) Hybrid with Enhanced Cytotoxicity through Inhibition of NRF2 Transcriptional Activity.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 29, p. 12160, doi. 10.1002/ange.202002992
- By:
- Publication type:
- Article
A novel image encryption algorithm based on coupled map lattices model.
- Published in:
- Multimedia Tools & Applications, 2024, v. 83, n. 4, p. 11557, doi. 10.1007/s11042-023-15964-z
- By:
- Publication type:
- Article
A novel image encryption algorithm using PWLCM map-based CML chaotic system and dynamic DNA encryption.
- Published in:
- Multimedia Tools & Applications, 2021, v. 80, n. 21-23, p. 32841, doi. 10.1007/s11042-021-11218-y
- By:
- Publication type:
- Article
Evidence for the persistence of an active endogenous retrovirus (ERVE) in humans.
- Published in:
- Genetica, 2014, v. 142, n. 5, p. 451, doi. 10.1007/s10709-014-9789-y
- By:
- Publication type:
- Article
Chronic Myelogenous Leukemia Presenting in Blast Phase with Nodal, Bilineal Myeloid Sarcoma and T-Lymphoblastic Lymphoma in a Child.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Epidural myeloid sarcoma as the presenting symptom of chronic myeloid leukemia blast crisis.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 8, p. 2453, doi. 10.1007/s10067-020-05167-4
- By:
- Publication type:
- Article
Regulatory network analysis of microRNAs and genes in imatinib-resistant chronic myeloid leukemia.
- Published in:
- Functional & Integrative Genomics, 2017, v. 17, n. 2/3, p. 263, doi. 10.1007/s10142-016-0520-1
- By:
- Publication type:
- Article
Moyamoya disease presenting with symptomatic ischemic stroke during new-generation tyrosine kinase inhibitor treatment: two illustrative cases.
- Published in:
- Acta Neurochirurgica, 2023, v. 165, n. 12, p. 3637, doi. 10.1007/s00701-023-05858-2
- By:
- Publication type:
- Article
New-generation tyrosine kinase inhibitor-associated asymptomatic cerebrovascular stenosis: two illustrative cases.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Viability of Tumor Cells (K562, Hep-2, HeLa) and Rat Fibroblasts in the Presence of Pterostilbene and Extracts of Licorice Root and Andrographis Paniculata.
- Published in:
- Pharmaceutical Chemistry Journal, 2021, v. 55, n. 9, p. 876, doi. 10.1007/s11094-021-02511-z
- By:
- Publication type:
- Article
Crystal Structure of Nilotinib Hydrochloride Monohydrate According to Powder X-Ray Diffraction Data.
- Published in:
- Journal of Structural Chemistry, 2024, v. 65, n. 3, p. 585, doi. 10.1134/S0022476624030132
- By:
- Publication type:
- Article
Bayesian analysis of the effect of exosomes in a mouse xenograft model of chronic myeloid leukemia.
- Published in:
- Electronic Research Archive, 2023, v. 31, n. 11, p. 1, doi. 10.3934/mbe.2023864
- By:
- Publication type:
- Article
Alteration of Blood Group in a Patient with Chronic Myelogenous Leukemia.
- Published in:
- Global Journal of Transfusion Medicine, 2024, v. 9, n. 1, p. 90, doi. 10.4103/gjtm.gjtm_16_24
- By:
- Publication type:
- Article
Investigating the role of CD47 gene regulation in Iraqi cancer patients: a promising prognostic factor.
- Published in:
- Iraqi Journal of Cancer & Medical Genetics, 2023, v. 16, n. 2, p. 66, doi. 10.29409/ijcmg.v16i2.338
- By:
- Publication type:
- Article
Synthesis of New Glucosylated Porphyrins Bearing an α‐d‐Linkage.
- Published in:
- Journal of Carbohydrate Chemistry, 2006, v. 25, n. 4, p. 345, doi. 10.1080/07328300600770527
- By:
- Publication type:
- Article
A systematic study of hematological and molecular response to generic imatinib mesylate therapy in patients of chronic myeloid leukemia.
- Published in:
- Indian Journal of Basic & Applied Medical Research, 2020, v. 9, n. 3, p. 95, doi. 10.36848/IJBAMR/2020/12225.51560
- By:
- Publication type:
- Article
海洋真菌 Penicillium sp. WP-13 次级代谢产物研究.
- Published in:
- Mycosystema, 2022, v. 41, n. 5, p. 782, doi. 10.13346/j.mycosystema.210438
- By:
- Publication type:
- Article
Inhibitory Effects of Rosemary Extracts, Carnosic Acid and Rosmarinic Acid on the Growth of Various Human Cancer Cell Lines.
- Published in:
- Plant Foods for Human Nutrition, 2010, v. 65, n. 2, p. 158, doi. 10.1007/s11130-010-0166-4
- By:
- Publication type:
- Article
اثر همزمان پروژسترون و بربرین بر سطح گونههای فعال اکسیژن در سلولهای K562.
- Published in:
- Journal of Birjand University of Medical Sciences, 2023, v. 30, n. 1, p. 99
- By:
- Publication type:
- Article
Privileged fragment-based design, synthesis and in vitro antitumor activity of imatinib analogues.
- Published in:
- Turkish Journal of Chemistry, 2023, v. 47, n. 2, p. 426, doi. 10.55730/1300-0527.3549
- By:
- Publication type:
- Article
Single-cell data revealed the function of natural killer cells and macrophage cells in chemotherapy tolerance in acute myeloid leukemia.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.18521
- By:
- Publication type:
- Article
Chikungunya virus time course infection of human macrophages reveals intracellular signaling pathways relevant to repurposed therapeutics.
- Published in:
- PeerJ, 2022, p. 1, doi. 10.7717/peerj.13090
- By:
- Publication type:
- Article
Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia.
- Published in:
- PeerJ, 2022, p. 1, doi. 10.7717/peerj.12616
- By:
- Publication type:
- Article
An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States.
- Published in:
- PeerJ, 2018, p. 1, doi. 10.7717/peerj.4342
- By:
- Publication type:
- Article
Overcoming Chronic Myeloid Leukemia Stem Cell Resistance to Imatinib by Also Targeting JAK2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 6, p. 378, doi. 10.1093/jnci/djt029
- By:
- Publication type:
- Article
The Challenge of Funding Research on Rare Malignancies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 22, p. 1650, doi. 10.1093/jnci/djr477
- By:
- Publication type:
- Article
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 7, p. 553, doi. 10.1093/jnci/djr060
- By:
- Publication type:
- Article
Twelfth Biannual Report of the Cochrane Haematological Malignancies Group—Focus on Tyrosine Kinase Inhibitors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 4, p. E1, doi. 10.1093/jnci/djq531
- By:
- Publication type:
- Article
Drug Developers Unveil Strategies Aimed at Imatinib-Resistant CML.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 9, p. 593, doi. 10.1093/jnci/djq163
- By:
- Publication type:
- Article
Mutation-Negative Leukemia and Persistent Activation of LYN Kinase.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 13, p. 926, doi. 10.1093/jnci/djn188
- By:
- Publication type:
- Article
Disease Progression in Some Cancers May Be Due to Low Blood Levels of Targeted Therapies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 13, p. 912, doi. 10.1093/jnci/djn230
- By:
- Publication type:
- Article
Persistent LYN Signaling in Imatinib-Resistant, BCR-ABL—lndependent Chronic Myelogenous Leukemia.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Chronic Myelogenous Leukemia Progenitors Display a Genetically Unstable Personality.
- Published in:
- 2007
- By:
- Publication type:
- Editorial